Document Detail

The incidence of chronic thromboembolic pulmonary hypertension secondary to acute pulmonary thromboembolism.
MedLine Citation:
PMID:  25492817     Owner:  NLM     Status:  Publisher    
Introduction: Chronic thromboembolic pulmonary hypertension (CTEPH) is a curable and partially preventable complication, with a substantial incidence, leading to severe morbidity and mortality. The aim of the present study was to find out the incidence of CTEPH secondary to acute pulmonary thromboembolism (PTE) using non-invasive procedures such as ventilation/perfusion (V/Q) scintigraphy and pulmonary multidetector CT (MDCT) angiography in determining the diagnosis of CTEPH. Materials and Methods: The study included a total of 99 patients diagnosed with initial PTE between January 2010 and December 2012. The patients who received anticoagulant therapy at least for three months underwent transthoracic echocardiography (TTE) (n= 85). Thirty one patients with a SPAP value > 30 mmHg and/or an evidence of right ventricular dysfunction in TTE underwent MDCT pulmonary angiography and V/Q scintigraphy. The patients with an evidence of residual chronic thromboembolic signs in MDCT pulmonary angiography and/or segmental perfusion defect(s) in V/Q scintigraphy underwent right heart catheterization (RHC) (n= 7). The mean PAP was measured, and a vasoreactivity test was performed. During RHC, a non-contrast medium was delivered to the pulmonary arteries for pulmonary arteriography imaging. Results: Among patients diagnosed with PTE, 44 were male and 55 were female. The mean age was 60 ± 17 years. Of these patients, 63.6% had history of at least one additional disease and at least one risk factor for PTE. During diagnosis, 24 subjects were considered having massive, 61 submassive and 14 non-massive PTE. Nineteen (19.1%) patients received thrombolythic therapy. Other 80 (80.8%) patients received standard anticoagulant therapy with an INR value within the therapeutic range. In 79.8% of patients, thromboembolism was bilateral, and it was unilateral in 21.8%. After a minimum of 1 year, and maximum of 2 years follow up five subjects (5.5%) were diagnosed with CTEPH. The univariate analysis showed no association between the development of CTEPH and factors like; age, etiologic risk factors for PTE, receiving thrombolytic treatment, prevalence and type of PTE. Conclusion: Potentially preventabl complication of pulmonary embolism; CTEPH, had a substantial incidence during follow-up.
Ismail Kayaalp; Yelda Varol; Pınar Cimen; Fatma Demirci Üçsular; Nuran Katgı; Mehmet Unlü; Cenk Kıraklı; Salih Zeki Güçlü; Oktay Ergene
Related Documents :
8301307 - Endothelin and aneurysmal subarachnoid haemorrhage: a study of subarachnoid cisternal c...
1376827 - Vascular mechanisms in hypertensive cerebrovascular disease.
23702737 - Morphology of the cerebral arterial circle in the prenatal and postnatal period of serb...
9756597 - Myosin light chain phosphorylation and contractile proteins in a canine two-hemorrhage ...
1137037 - Anatomy of the thalamoperforating arteries with special emphasis on arteriography of th...
65157 - Antithrombin iii deficiency causing postsplenectomy mesenteric venous thrombosis coinci...
Publication Detail:
Journal Detail:
Title:  Tuberkuloz ve toraks     Volume:  62     ISSN:  0494-1373     ISO Abbreviation:  Tuberk Toraks     Publication Date:  2014 Sep 
Date Detail:
Created Date:  2014-12-10     Completed Date:  -     Revised Date:  2014-12-11    
Medline Journal Info:
Nlm Unique ID:  0417364     Medline TA:  Tuberk Toraks     Country:  -    
Other Details:
Languages:  ENG     Pagination:  199-206     Citation Subset:  -    
Vernacular Title:
Akut pulmoner tromboemboli sonrası gelişen kronik tromboembolik pulmoner hipertansiyon sıklığı
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  The evaluation of arsenic and cadmium levels in biological samples of cases with lung cancer.
Next Document:  Association of obstructive sleep apnea with homocystein, nitric oxide and total antioxidant capacity...